Gout therapeutics: new drugs for an old disease
- 1 January 2011
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 377 (9760), 165-177
- https://doi.org/10.1016/s0140-6736(10)60665-4
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- GoutThe Lancet, 2010
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot studyAnnals Of The Rheumatic Diseases, 2009
- Gout. Novel therapies for treatment of gout and hyperuricemiaArthritis Research & Therapy, 2009
- Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in HumansOnline Journal of Public Health Informatics, 2008
- Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005Annals Of The Rheumatic Diseases, 2007
- A pilot study of IL-1 inhibition by anakinra in acute goutArthritis Research & Therapy, 2007
- Validity of gout diagnoses in administrative dataArthritis Care & Research, 2007
- MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystalsJCI Insight, 2006
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals Of The Rheumatic Diseases, 2006
- EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)Annals Of The Rheumatic Diseases, 2006